1. Medtech Insight

Minute Insight: Abbott Launches Mixed-Reality Experience To Make Blood Donation Easier

 
• By Reed Miller

Abbott will provide an immersive mixed reality experience for blood donors at Blood Centers of America. The company expects that making blood donation more pleasant will help to attract new donors and motivate a younger generation to give blood.

Minute Insight
• Source: Informa/Alamy

Abbott is working with the with Blood Centers of America (BCA), the largest blood supplier network in the US, to provide blood donors with an immersive mixed reality experience that reduces blood donors’ anxiety during a blood draw.

The mixed-reality experience allows blood donors to “visit a whimsical garden and plant seeds as a way to have an experience while they're donating blood,” Abbott spokesperson Patrick O’Connell told

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight

SS Innovations Files For De Novo For SSi Mantra 3 Surgical Robotic System For Multispecialty Indications

 
• By Marion Webb

SS Innovations announced plans to file a de novo application with the US FDA for its SSi Mantra 3 surgical robot, already approved for marketing in six countries. The Florida-based firm also plans to pursue the CE mark for European commercialization.

Faster Device Certification Among Keys To Unlocking Innovation In EU MedTech Sector

 
• By Amanda Maxwell

While MedTech Europe sharpens its focus on what the EU most urgently needs to advance the medtech market in four targeted measures, the European Commission has also unveiled four priorities for 2025.

Will NICE’s New Medtech Evaluation Plans Hit the Target for Patients and Industry?

 
• By Ashley Yeo

One year after the UK mooted the Rules-Based Pathway to give medtechs clarity on what can be expected from an evaluation, the devices industry says UK healthtech assessment and adoption processes are still failing to meet the needs of innovators and patients.